Navigation Links
Dallas-Fort Worth Fertility Associates Celebrates First Birth in North Texas from Advanced Trophectoderm Biopsy Screening Technology
Date:12/18/2012

Dallas, Texas (PRWEB) December 18, 2012

Dallas-Fort Worth Fertility Associates announces one of North Texas’ first live births with blastocyst embryo biopsy, an emerging technology used to screen embryos for chromosomal abnormalities before embryo transfer in an in vitro fertilization cycle.

This method uses an advanced laser system to create an opening in the outer shell of an embryo, then to remove cells from the “trophectoderm,” the outer part of a blastocyst (5-day old embryo) that ultimately develops into the placenta. A trophectoderm biopsy of the blastocyst significantly improves the chances for conception for parents experiencing infertility compared to other embryo biopsy technologies.

“The success of this pregnancy signifies the viability of trophectoderm biopsy as another resource to help couples achieve their parenthood dreams,” explained Dr. Sam Chantilis, medical director of Dallas-Fort Worth Fertility Associates.

To view video of Trophectoderm Biopsy, Click Here

In the current case, Dr. Chantillis was working with a couple that had specific concerns about a sex-linked genetic abnormality. Dallas-Fort Worth Fertility Associates utilized the trophectoderm biopsy to look for healthy female embryos before performing the transfer.

“It was important that this patient and her husband not have to worry about passing on any genetic disorders to their children,” said Dr. Chantilis.

With the trophectoderm biopsy, embryologists can perform a thorough genetic analysis of multiple cells on five-day-old embryos. In the past, technicians could only assess the genetic material of one cell from an embryo on the third day after IVF egg retrieval.

“Before this, preimplantation genetic screening (PGS) was performed in the fertility lab using the genetic material from one cell of an eight-cell embryo,” Dr. Chantillis said. “The limited amount of available genetic material in the eight-cell embryo and genetic variability of the various cells in a three-day old embryo made the analysis less accurate.”

Dr. Chantillis explains that the trophectoderm biopsy enables embryologists to remove the cells when the embryos are five and six days old and has developed 60 to 80 cells. This allows fertility specialists to screen the X and Y chromosomes, as well as 22 autosomal chromosomes.

The new PGS protocol evaluates the embryos on Day 5, so the final transfer is delayed at least one month. Once the best embryos are identified, they are preserved using an innovative fast-freezing process called vitrification. The improved method of preserving embryos results in less damage during freezing and thawing.

“This technology is the wave of the future for reproductive medicine,” Dr. Chantilis said. “We are thrilled to have another tool in our arsenal that allows us to help those struggling with infertility create their families.”

About Dallas Fertility Associates
Dallas-Fort Worth Fertility Associates is a private practice physicians' office specializing in reproductive endocrinology and infertility treatment. Dr. Samuel J. Chantilis, Dr. Karen L. Lee, Dr. Mika R. Thomas and Dr. Ravi Gada, our fertility specialists, are all fellowship-trained in reproductive endocrinology and infertility. Our clinic was opened in an effort to bring the latest IVF treatments and procedures to the Dallas-Fort Worth community. For more information, please visit http://www.dallasfertility.com.

Read the full story at http://www.prweb.com/releases/DFA/2012/prweb10229756.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Global Membrane Bioreactor (MBR) Systems Market Worth $2,052 Million by 2017
2. Global Biobank Market Worth $3.9 Billion by 2017
3. Global Medical Image Analysis Software Market Worth $2.4 Billion by 2017
4. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
5. MarketsandMarkets: Global Spine Surgery Devices Market Worth $14.8 Billion by 2017
6. The Law Office of Roger G. Worthington, P.C. - Longtime Supporter of the Pacific Meso Center - Donates $100,000 for Mesothelioma Research
7. MarketsandMarkets: Global Next Generation Biometric Technologies Market worth $13.89 Billion by 2017
8. Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets
9. Professor Doel Soejarto to Receive ABCs Farnsworth Excellence in Botanical Research Award
10. MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016
11. MarketsandMarkets: Global Clinical Trial Management Systems Market Worth $1300.4 Million by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
(Date:6/22/2016)... 2016   StockNewsNow.com , The Official MicroCap News ... Nader Pourhassan , President & CEO of CytoDyn ... clinical development and potential commercialization of humanized monoclonal antibodies ... to the company,s website (see here: www.CytoDyn.com ). ... th , 2016, at the LD Micro Invitational in ...
(Date:6/22/2016)... June 22, 2016  Mesa Biotech Inc., a ... testing platform designed specifically for point-of-care (POC) infectious ... scientific advisory board (SAB). Approved by the executive ... is chartered to advise on the development and ... Led by Dr. Steve Young , this ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):